Takeda Pharmaceutical has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...
Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...
MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...
Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...
A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...
Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazola...
Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in&nb...
Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...
Following the announcement of positive results from Janssen’s Phase III open-label long-term extension study, whic...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity a...
Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support f...
The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Li...
China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi T...
